ZA200110504B - Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria. - Google Patents

Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.

Info

Publication number
ZA200110504B
ZA200110504B ZA200110504A ZA200110504A ZA200110504B ZA 200110504 B ZA200110504 B ZA 200110504B ZA 200110504 A ZA200110504 A ZA 200110504A ZA 200110504 A ZA200110504 A ZA 200110504A ZA 200110504 B ZA200110504 B ZA 200110504B
Authority
ZA
South Africa
Prior art keywords
hyperoxaluria
dietary
prevention
treatment
pharmaceutical compositions
Prior art date
Application number
ZA200110504A
Other languages
English (en)
Inventor
Claudio De Simone
Original Assignee
Vsl Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd
Publication of ZA200110504B publication Critical patent/ZA200110504B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA200110504A 1999-05-28 2001-12-21 Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria. ZA200110504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso

Publications (1)

Publication Number Publication Date
ZA200110504B true ZA200110504B (en) 2002-09-25

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200110504A ZA200110504B (en) 1999-05-28 2001-12-21 Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.

Country Status (34)

Country Link
US (2) US6562336B2 (fr)
EP (1) EP1181027B1 (fr)
JP (1) JP4737836B2 (fr)
KR (1) KR100781703B1 (fr)
CN (1) CN100350919C (fr)
AR (1) AR024555A1 (fr)
AT (1) ATE265857T1 (fr)
AU (1) AU773459B2 (fr)
BR (1) BR0011038B1 (fr)
CA (1) CA2373255C (fr)
CZ (1) CZ20014076A3 (fr)
DE (1) DE60010456T2 (fr)
DK (1) DK1181027T3 (fr)
DZ (1) DZ3165A1 (fr)
EA (1) EA004257B1 (fr)
EE (1) EE200100618A (fr)
ES (1) ES2219344T3 (fr)
HK (1) HK1048066B (fr)
HU (1) HU225134B1 (fr)
IL (3) IL146703A0 (fr)
IS (1) IS6150A (fr)
IT (1) IT1309427B1 (fr)
MA (1) MA26790A1 (fr)
MX (1) MXPA01012184A (fr)
NO (1) NO20015782L (fr)
NZ (1) NZ516020A (fr)
PL (1) PL352014A1 (fr)
PT (1) PT1181027E (fr)
SI (1) SI1181027T1 (fr)
SK (1) SK16612001A3 (fr)
TR (1) TR200103439T2 (fr)
UA (1) UA71621C2 (fr)
WO (1) WO2000072855A2 (fr)
ZA (1) ZA200110504B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
CN1812801A (zh) * 2003-06-24 2006-08-02 大塚制药株式会社 降低血清尿酸水平的组合物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
RU2006136927A (ru) 2004-03-19 2008-04-27 Даниско А/С (Dk) Композиция эмульгатора для шортенинга
WO2006047680A2 (fr) * 2004-10-27 2006-05-04 North Carolina State University Acides nucleiques de lactobacillus acidophilus et leurs procedes d'utilisation
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
WO2007070052A2 (fr) 2005-12-14 2007-06-21 Oxthera, Inc. Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
US8900575B2 (en) 2005-12-16 2014-12-02 Oxthera Intellectual Property Ab Compositions and methods for oxalate reduction
US20080241226A1 (en) * 2007-03-27 2008-10-02 Abeln Susan L Methods and Kits For Administering Probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
JP5632289B2 (ja) 2008-09-30 2014-11-26 株式会社明治 高いシュウ酸分解能を有する乳酸菌
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
EP3237600B1 (fr) * 2014-10-01 2020-04-29 Triphase Pharmaceuticals Pvt. Ltd. Souches thermostables, produits et procédés associés
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
CN107868776A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
CA3122756A1 (fr) * 2018-12-10 2020-06-18 Novome Biotechnologies, Inc. Methodes et compositions pour le traitement de l'hyperoxalurie
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
ES2334409T3 (es) * 1997-05-23 2010-03-09 Oxthera, Inc., Microorganismos degradantes del oxalato o enzimas degradantes del oxalato para prevenir enfermedades relacionadas con el oxalato.
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
CN100350919C (zh) 2007-11-28
DK1181027T3 (da) 2004-08-16
JP2003500451A (ja) 2003-01-07
EP1181027B1 (fr) 2004-05-06
NO20015782L (no) 2002-01-25
PL352014A1 (en) 2003-07-14
KR100781703B1 (ko) 2007-12-03
BR0011038A (pt) 2002-02-26
SK16612001A3 (sk) 2002-04-04
BR0011038B1 (pt) 2014-02-18
EE200100618A (et) 2003-02-17
ES2219344T3 (es) 2004-12-01
IL146703A (en) 2010-03-28
EA200101262A1 (ru) 2002-04-25
DE60010456D1 (de) 2004-06-09
IT1309427B1 (it) 2002-01-23
AU773459B2 (en) 2004-05-27
HU225134B1 (en) 2006-06-28
KR20020019918A (ko) 2002-03-13
AR024555A1 (es) 2002-10-16
EA004257B1 (ru) 2004-02-26
CN1365284A (zh) 2002-08-21
MXPA01012184A (es) 2003-06-30
HK1048066A1 (en) 2003-03-21
USRE39585E1 (en) 2007-04-24
CZ20014076A3 (cs) 2002-03-13
CA2373255A1 (fr) 2000-12-07
NZ516020A (en) 2003-06-30
IL199437A (en) 2016-10-31
JP4737836B2 (ja) 2011-08-03
EP1181027A2 (fr) 2002-02-27
US6562336B2 (en) 2003-05-13
DE60010456T2 (de) 2005-05-12
ATE265857T1 (de) 2004-05-15
DZ3165A1 (fr) 2000-12-07
IL146703A0 (en) 2002-07-25
UA71621C2 (en) 2004-12-15
CA2373255C (fr) 2010-01-19
IL199437A0 (en) 2011-07-31
US20020061292A1 (en) 2002-05-23
SI1181027T1 (en) 2004-08-31
IS6150A (is) 2001-11-08
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
NO20015782D0 (no) 2001-11-27
WO2000072855A2 (fr) 2000-12-07
PT1181027E (pt) 2004-09-30
HUP0201409A2 (en) 2002-08-28
WO2000072855A3 (fr) 2001-06-28
HUP0201409A3 (en) 2004-10-28
AU5101600A (en) 2000-12-18
TR200103439T2 (tr) 2002-06-21
ITRM990338A0 (it) 1999-05-28
MA26790A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
HK1046240A1 (en) Pharmaceutical compositions for the treatment of insulin resistance
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
GB9916536D0 (en) Nutritional or pharmaceutical compositions
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
WO2000066104A3 (fr) Composes inhibant ace-2 et leurs procedes d'utilisation
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
IL148691A0 (en) Pharmaceutical compositions containing ciclesonide
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
ZA971036B (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections.
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
AU1792200A (en) Use of phanquinone for the treatment or prevention of memory impairment
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL122883A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
ZA200400480B (en) A synergistic pharmaceutical combination for the prevention or treatment of diabetes.
AU4222400A (en) Methods and compositions for the treatment and prevention of lung disease